BrainsWay Announces Multiple Publications of New Real-World OCD Data for its Deep TMS(TM) System
Positive Data Support the Durability and Cost-Effectiveness of Deep TMS as a Treatment for Obsessive-Compulsive Disorder BURLINGTON, Mass. and JERUSALEM, Israel, Jan. 12, 2022 (GLOBE NEWSWIRE) — BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or more...
Bionano Genomics Reports Preliminary Fourth Quarter and Full-Year 2021 Results
– Preliminary Q4 revenue expected between $5.8 and $6.2 million; 45%-55% increase over Q4 2020 – Reached installed base of 164 systems: 69% increase over YE 2020 – Achieved or exceeded all stated goals and more...
Avinger Announces $7.6 Million Registered Direct Offering
REDWOOD CITY, CA / ACCESSWIRE / January 12, 2022 / Avinger, Inc. (NASDAQ:AVGR) (the “Company”), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of Peripheral more...
Heat Biologics Announces New PTX-35 Preclinical Data in Organ Transplantation and Provides Update on HS-110
Data demonstrates that PTX-35 may have utility in solid organ transplantation, and to potentially slow or mitigate deleterious immune responses where self-tissue tolerance is impaired DURHAM, N.C., Jan. 12, 2022 (GLOBE NEWSWIRE) — Heat Biologics, more...
Hepion Pharmaceuticals Announces Death of Director, Thomas Adams
EDISON, N.J., Jan. 12, 2022 (GLOBE NEWSWIRE) — It is with profound sadness that Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA) announces the passing of Thomas Adams, Ph.D., a member of its Board of Directors. Dr. Adams died more...
AUDACIOUS ENTERS INTO DEFINITIVE AGREEMENT WITH GOLDEN TRIANGLE HEALTH
AUDACIOUS ENTERS INTO DEFINITIVE AGREEMENT WITH GOLDEN TRIANGLE HEALTH PR Newswire Agreement marks the first commercial shipment of CBD hemp seeds to Asia by a North American company and kicks off AUDACIOUS’ revenue generating initiatives more...
5 Top Stocks That Are Powered by Relative Price Strength
While a highly successful 2021 propelled the U.S. equity markets to historic levels, the resurgence of coronavirus either in the form of Delta or Omicron has been creating intermittent hurdles. Therefore, as we step into more...
Phexxi Access to Expand under New Government Guidance Stating Insurers Must Cover FDA-approved Contraceptives with No Out-of-Pocket Costs to Women
Phexxi Access to Expand under New Government Guidance Stating Insurers Must Cover FDA-approved Contraceptives with No Out-of-Pocket Costs to Women PR Newswire SAN DIEGO , Jan. 12, 2022 /PRNewswire/ — Evofem Biosciences, Inc. (NASDAQ: EVFM) more...
Illumina (ILMN) Announces Preliminary Q4 Sales, Issues ’22 View
Illumina, Inc. ILMN recently announced preliminary fourth-quarter and full-year 2021 revenues along with 2022 top-line guidance at the 2022 J.P. Morgan Healthcare Conference. The company also discussed its latest partnerships and product pipelines, defining its more...
Sugarbud Announces Timing of Annual General Meeting, Mailing of Meeting Materials and Details of Proposed Share Consolidation
CALGARY, Alberta, Jan. 11, 2022 (GLOBE NEWSWIRE) — Sugarbud Craft Growers Corp. (TSXV: SUGR, SUGR.DB, SUGR.WR, SUGR.WS, SUGR.WT) (OTCQB: SBUDF) (” Sugarbud ” or the ” Compan y”) announces that it has mailed a management more...